SCHEMBL23745653

SCHEMBL23745653

O=C(CC(c1cccnc1)c1cn(Cc2ccccc2)c2ccccc12)NCCN1CCCC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
LMNA P02545 2/20 0.45
HPGD P15428 2/20 0.45
HTT P42858 1/20 0.45
ALDH1A1 P00352 3/20 0.43
POLB P06746 2/20 0.43
USP2 O75604 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HTR2C P28335 1/20 0.43
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
RAB9A P51151 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SLC1A2 P43004 1/20 0.41
GLA P06280 1/20 0.40
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23721925 0.99 SMN1; SMN2 (0.44) SMN1; SMN2LMNAHPGDHTTALDH1A1
SCHEMBL23721942 0.85 CACNA1G (0.46) SMN1; SMN2LMNAHPGDHTTALDH1A1
Hydrochloric Acid SCHEMBL23722141 0.84 CACNA1G (0.45) SMN1; SMN2LMNAHPGDHTTALDH1A1
SCHEMBL23516678 0.83 ALDH1A1 (0.44) SMN1; SMN2HPGDHTTALDH1A1POLB
SCHEMBL23745704 0.83 ALDH1A1 (0.45) SMN1; SMN2HPGDHTTALDH1A1POLB
SCHEMBL23745498 0.83 MTNR1A (0.45) LMNAALDH1A1POLBUSP2HSD17B10
Hydrochloric Acid SCHEMBL23721986 0.82 ALDH1A1 (0.44) SMN1; SMN2HPGDHTTALDH1A1POLB
SCHEMBL23745645 0.82 ACHE (0.47) SMN1; SMN2LMNAHPGDHTTALDH1A1
SCHEMBL23745692 0.82 LMNA (0.42) SMN1; SMN2LMNAHPGDHTTALDH1A1
SCHEMBL23745564 0.81 ALDH1A1 (0.43) HTTALDH1A1POLBUSP2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 SMN1; SMN2 4414/4885LMNA 2573/4885HPGD 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.